RESUMO
Osteocalcin (OCN), the most abundant noncollagenous protein in the bone matrix, is reported to be a bone-derived endocrine hormone with wide-ranging effects on many aspects of physiology, including glucose metabolism and male fertility. Many of these observations were made using an OCN-deficient mouse allele (Osc-) in which the 2 OCN-encoding genes in mice, Bglap and Bglap2, were deleted in ES cells by homologous recombination. Here we describe mice with a new Bglap and Bglap2 double-knockout (dko) allele (Bglap/2p.Pro25fs17Ter) that was generated by CRISPR/Cas9-mediated gene editing. Mice homozygous for this new allele do not express full-length Bglap or Bglap2 mRNA and have no immunodetectable OCN in their serum. FTIR imaging of cortical bone in these homozygous knockout animals finds alterations in the collagen maturity and carbonate to phosphate ratio in the cortical bone, compared with wild-type littermates. However, µCT and 3-point bending tests do not find differences from wild-type littermates with respect to bone mass and strength. In contrast to the previously reported OCN-deficient mice with the Osc-allele, serum glucose levels and male fertility in the OCN-deficient mice with the Bglap/2pPro25fs17Ter allele did not have significant differences from wild-type littermates. We cannot explain the absence of endocrine effects in mice with this new knockout allele. Possible explanations include the effects of each mutated allele on the transcription of neighboring genes, or differences in genetic background and environment. So that our findings can be confirmed and extended by other interested investigators, we are donating this new Bglap and Bglap2 double-knockout strain to the Jackson Laboratories for academic distribution.
Assuntos
Sistema Endócrino/fisiologia , Osteocalcina/genética , Animais , Densidade Óssea/genética , Osso e Ossos/metabolismo , Sistema Endócrino/metabolismo , Feminino , Fertilidade/genética , Resistência à Insulina/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Osteocalcina/deficiênciaRESUMO
BACKGROUND: HIV infection is now largely a chronic condition as a result of the success of antiretroviral therapy. However, several comorbidities have emerged in people living with HIV (PLWH), including alcohol use disorders and musculoskeletal disorders. Alcohol use has been associated with lower bone mineral density, alterations to circulating bone turnover markers, and hypocalcemia. The pathophysiological basis of bone loss in the PLWH population is unclear but has been suggested to be linked to oxidative stress and inflammation. To test the hypothesis that PLWH consuming excessive alcohol have altered markers of bone turnover and/or calcium homeostasis in association with oxidative stress, we correlated measurements of alcohol consumption with markers of oxidative stress and inflammation, serum calcium concentrations, and measurements of bone turnover, including c-terminal telopeptide cross-links (CTX-1) and osteocalcin. METHODS: Data were drawn from cross-sectional baseline data from the ongoing New Orleans Alcohol Use in HIV (NOAH) study, comprised of 365 in care PLWH. Alcohol consumption measures (Alcohol Use Disorders Test, 30-day timeline follow-back calendar, and phosphatidylethanol [PEth]) were measured in a subcohort of 40 subjects selected based on highest and lowest PEth measurements. Multivariate linear regression was performed to test the relationships between alcohol consumption and systemic oxidative stress (4-hydroxynonenal; 4-HNE) and inflammation (c-reactive protein; CRP). RESULTS: Serum calcium and CTX-1 did not differ significantly between the high and low-PEth groups. Individuals in the high-PEth group had significantly lower serum osteocalcin (median low-PEth group: 13.42 ng/ml, inter-quartile range [IQR] 9.26 to 14.99 ng/ml; median high-PEth group 7.39 ng/ml, IQR 5.02 to 11.25 ng/ml; p = 0.0005, Wilcoxon rank-sum test). Osteocalcin negatively correlated with PEth (Spearman r = -0.45, p = 0.05) and self-reported measures after adjusting for covariates. Alcohol consumption showed mild, but significant, positive associations with serum 4-HNE, but not with CRP. Osteocalcin did not correlate with either 4-HNE or CRP. CONCLUSIONS: In this subcohort of PLWH, we detected significant associations between at-risk alcohol use and osteocalcin, and at-risk alcohol use and serum 4-HNE, suggesting suppression of bone formation independent of increased systemic oxidative stress with increasing alcohol consumption.
Assuntos
Alcoolismo/complicações , Infecções por HIV/complicações , Inflamação/complicações , Osteocalcina/deficiência , Estresse Oxidativo , Alcoolismo/sangue , Alcoolismo/metabolismo , Cálcio/sangue , Cálcio/metabolismo , Estudos Transversais , Feminino , Glicerofosfolipídeos/sangue , Infecções por HIV/sangue , Infecções por HIV/metabolismo , Humanos , Inflamação/sangue , Inflamação/metabolismo , Masculino , Nova Orleans , Osteocalcina/sangue , Estresse Oxidativo/efeitos dos fármacosRESUMO
Osteocalcin (OC) is an abundant extracellular calcium-binding protein synthesized by osteoblasts. Although most OC is bound to hydroxyapatite mineral during bone formation, a consistent amount is released directly to circulation. Plasma OC (pOC) levels are highly sensitive to stressful stimuli that alter stress-responsive hormones, such as glucocorticoids (cortisol or corticosterone) and the catecholamines norepinephrine and epinephrine. To gain a better understanding of the apparent relationship of OC to the effects of ethanol (EtOH) and the stress responses, we compared mice that have OC (WT [OC+/+] and HET [OC+/-]) with OC null mutants (KO [OC-/-]), which have no OC in either plasma or in bone. One experiment included chronic unpredictable stress, a second was conducted in the absence of any known stressors other than EtOH, while a third imposed a more severe acute immobilization stress in addition to EtOH consumption. The data obtained confirmed significant differences in EtOH consumption in mice that previously experienced various stressful stimuli. We also determined that adrenal tyrosine-hydroxylase expression was inversely proportional to EtOH consumption and tended to be lower in KO than in WT. Data suggest that OC possesses the ability to modulate the adrenal gene expression of the catecholamine synthetic pathway. This modulation may be responsible for differences in EtOH consumption under stress.
Assuntos
Consumo de Bebidas Alcoólicas/metabolismo , Osteocalcina/deficiência , Estresse Psicológico/metabolismo , Consumo de Bebidas Alcoólicas/genética , Animais , Etanol/administração & dosagem , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Osteocalcina/genética , Estresse Psicológico/genética , Estresse Psicológico/psicologiaRESUMO
Osteocalcin (OC) and osteopontin (OPN) are major non-collagenous proteins (NCPs) involved in bone matrix organization and deposition. In spite of this, it is currently unknown whether OC and OPN alter bone morphology and consequently affect bone fracture resistance. The goal of this study is to establish the role of OC and OPN in the determination of cortical bone size, shape, and mechanical properties. Our results show that Oc-/- and Opn-/- mice were no different from each other or wild type (WT) with respect to bone morphology (P > 0.1). Bones from mice lacking both NCPs (Oc-/- Opn-/- ) were shorter, with thicker cortices and larger cortical areas, compared with the WT, Oc-/- , and Opn-/- groups (P < 0.05), suggesting a synergistic role for NCPs in the determination of bone morphology. Maximum bending load was significantly different among the groups (P = 0.024), while tissue mineral density and measures of stiffness and strength were not different (P > 0.1). We conclude that the removal of both OC and OPN from bone matrix induces morphological adaptation at the structural level to maintain bone strength.
Assuntos
Osso e Ossos/metabolismo , Osteocalcina/genética , Osteogênese/genética , Osteopontina/genética , Animais , Desenvolvimento Ósseo/genética , Osso e Ossos/patologia , Osso e Ossos/fisiopatologia , Masculino , Fenômenos Mecânicos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Osteocalcina/deficiência , Osteopontina/deficiênciaRESUMO
Osteocalcin, also known as bone γ-carboxyglutamate protein (Bglap), is expressed by osteoblasts and is commonly used as a clinical marker of bone turnover. A mouse model of osteocalcin deficiency has implicated osteocalcin as a mediator of changes to the skeleton, endocrine system, reproductive organs and central nervous system. However, differences between mouse and human osteocalcin at both the genome and protein levels have challenged the validity of extrapolating findings from the osteocalcin-deficient mouse model to human disease. The rat osteocalcin (Bglap) gene locus shares greater synteny with that of humans. To further examine the role of osteocalcin in disease, we created a rat model with complete loss of osteocalcin using the CRISPR/Cas9 system. Rat osteocalcin was modified by injection of CRISPR/Cas9 mRNA into the pronuclei of fertilized single cell Sprague-Dawley embryos, and animals were bred to homozygosity and compound heterozygosity for the mutant alleles. Dual-energy X-ray absorptiometry (DXA), glucose tolerance testing (GTT), insulin tolerance testing (ITT), microcomputed tomography (µCT), and a three-point break biomechanical assay were performed on the excised femurs at 5 months of age. Complete loss of osteocalcin resulted in bones with significantly increased trabecular thickness, density and volume. Cortical bone volume and density were not increased in null animals. The bones had improved functional quality as evidenced by an increase in failure load during the biomechanical stress assay. Differences in glucose homeostasis were observed between groups, but there were no differences in body weight or composition. This rat model of complete loss of osteocalcin provides a platform for further understanding the role of osteocalcin in disease, and it is a novel model of increased bone formation with potential utility in osteoporosis and osteoarthritis research.
Assuntos
Sistemas CRISPR-Cas/genética , Osso Esponjoso/fisiologia , Osteocalcina/deficiência , Absorciometria de Fóton , Alelos , Sequência de Aminoácidos , Animais , Sequência de Bases , Fenômenos Biomecânicos , Composição Corporal , Osso Esponjoso/diagnóstico por imagem , Fêmur/diagnóstico por imagem , Fêmur/fisiologia , Efeito Fundador , Técnicas Genéticas , Teste de Tolerância a Glucose , Mutação INDEL/genética , Insulina/metabolismo , Masculino , Modelos Animais , Osteocalcina/química , Osteocalcina/metabolismo , Ratos , Especificidade da Espécie , Microtomografia por Raio-XRESUMO
CONTEXT: The relationship between bone turnover markers and atherosclerosis is controversial. OBJECTIVE: The purpose of this study was to determine the association of arterial stiffness with the levels of osteocalcin and C-terminal telopeptide of type I collagen (CTx). DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included 1691 men and 1913 women who participated in the medical examination programs of a hospital from March 2008 to December 2011. MAIN OUTCOME MEASURES: Arterial stiffness was estimated by brachial-ankle pulse wave velocity (baPWV). Osteocalcin and CTx were assayed by chemiluminescence immunoassay. Bone mineral density was measured by dual-energy X-ray absorptiometry. RESULTS: The mean baPWV was elevated at both ends of the osteocalcin quintiles in both men and women. However, the adjusted mean was higher in the lowest quintile of osteocalcin than in the other quintiles in men and women. Before adjustment, negative and positive relationships of baPWV with the levels of osteocalcin and CTx were observed in men (ß = -0.123 and -0.078 for osteocalcin and CTx, respectively) and women (ß = 0.151 and 0.193), respectively. After adjustment for age and metabolic parameters, osteocalcin was negatively related with baPWV at lower osteocalcin levels (Q1-Q2) in both sexes (in the fully adjusted model, ß = -0.090 for men and -0.053 for women). No significant relationship was observed at higher values. The osteocalcin level was fit for a quadratic model for baPWV showing an inverse J-shape. CONCLUSIONS: The level of serum osteocalcin showed an inverse J-shaped relationship with arterial stiffness in both men and women. However, the association between the CTx level and arterial stiffness was not significant.
Assuntos
Osteocalcina/deficiência , Rigidez Vascular/genética , Idoso , Índice Tornozelo-Braço , Densidade Óssea , Colágeno Tipo I/sangue , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Peptídeos/sangue , Análise de Onda de Pulso , República da Coreia/epidemiologia , Caracteres SexuaisRESUMO
A recent unexpected development of bone biology is that bone is an endocrine organ regulating a growing number of physiological processes. One of the functions regulated by bone through the hormone osteocalcin is glucose homeostasis. In this overview, we will explain why we hypothesized that bone mass and energy metabolism should be subjected to a coordinated endocrine regulation. We will then review the experiments that revealed the endocrine function of osteocalcin and the cell biology events that allow osteocalcin to become a hormone. We will also illustrate the importance of this regulation to understand whole-body glucose homeostasis in the physiological state and in pathological conditions. Lastly, we will mention epidemiological and genetic evidence demonstrating that this function of osteocalcin is conserved in humans.
Assuntos
Metabolismo Energético/fisiologia , Glucose/metabolismo , Homeostase/fisiologia , Osteocalcina/fisiologia , Animais , Densidade Óssea/fisiologia , Modelos Animais de Doenças , Sistema Endócrino/fisiologia , Humanos , Insulina/fisiologia , Camundongos , Camundongos Knockout , Osteocalcina/deficiência , Osteocalcina/genéticaRESUMO
BACKGROUND: Recently, osteocalcin (OC), an osteoblast-derived hormone, has been suggested as a new link between obesity and insulin resistance in humans. However, few studies regarding the relationship between OC and obesity in Asian children have been published. We investigated the association of OC with adiposity, insulin resistance and metabolic syndrome (MetS) in Korean children. METHODS: Two hundred and nine (100 boys, 109 girls) children (age: 9.78 ± 1.05 years, body mass index (BMI): 22.27 ± 5.34 kg/m(2)) participated in this cross-sectional study. Anthropometric parameters, insulin resistance, lipid profiles, total OC, and an inflammatory marker, C-reactive protein (CRP), were measured. MetS phenotype was also determined. RESULTS: Serum total OC levels were significantly lower in overweight or obese children (76.96 ± 27.08 ng/ml vs. 66.91 ± 21.39 ng/ml, p = 0.020) and it was negatively associated with body fat after controlling for age, gender and BMI. Serum total OC concentrations were significantly lower in participants with central obesity or at least two components of MetS driven by waist circumference than they were in those with none. Stepwise linear regression results also showed that serum total OC was partially explained by age, gender, waist-to-hip ratio, and fasting glucose. CONCLUSIONS: This study supported a negative association between serum total OC and adiposity in children. OC may be associated with childhood central obesity; however, further research using more accurate measurements is needed to identify the association between these variables.
Assuntos
Glicemia/metabolismo , Proteína C-Reativa/metabolismo , Lipídeos/sangue , Síndrome Metabólica/sangue , Obesidade Abdominal/sangue , Osteocalcina/sangue , Índice de Massa Corporal , Criança , Estudos Transversais , Feminino , Humanos , Resistência à Insulina , Masculino , Síndrome Metabólica/epidemiologia , Síndrome Metabólica/prevenção & controle , Obesidade Abdominal/epidemiologia , Obesidade Abdominal/prevenção & controle , Osteocalcina/deficiência , Fenótipo , Valor Preditivo dos Testes , República da Coreia , Fatores de Risco , Circunferência da CinturaRESUMO
Osteocalcin, the most abundant member of the family of extracellular mineral binding gamma-carboxyglutamic acid proteins is synthesized primarily by osteoblasts. Its affinity for calcium ions is believed to limit bone mineralization. Several of the numerous hormones that regulate synthesis of osteocalcin, including glucocorticoids and parathyroid hormone, are also affected by stressful stimuli that require energy for an appropriate response. Based on our observations of OC responding to stressful sensory stimuli, the expression of OC in mouse and rat sensory ganglia was confirmed. It was thus hypothesized that the behavioral responses of the OC knockout mouse to stressful sensory stimuli would be abnormal. To test this hypothesis, behaviors related to sensory aspects of the stress response were quantified in nine groups of mice, aged 4-14 months, comparing knockout with their wild-type counterparts in six distinctly different behavioral tests. Resulting data indicated the following statistically significant differences: open field grooming frequency following saline injection, wild-type > knockout; paw stimulation with Von Frey fibers, knockout < wild-type; balance beam, knockout mobility < WT; thermal sensitivity to heat (tail flick), knockout < wild-type; and cold, knockout < wild-type. Insignificant differences in hanging wire test indicate that these responses are unrelated to reduced muscle strength. Each of these disparate environmental stimuli provided data indicating alterations of responses in knockout mice that suggest participation of osteocalcin in transmission of information about those sensory stimuli.
Assuntos
Neuropeptídeos/metabolismo , Osteocalcina/deficiência , Sensação/fisiologia , Animais , Osso e Ossos/metabolismo , Temperatura Baixa , Gânglios/metabolismo , Regulação da Expressão Gênica , Asseio Animal , Temperatura Alta , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Sistema Nervoso/metabolismo , Osteocalcina/genética , Osteocalcina/metabolismo , Ratos , Reação em Cadeia da Polimerase em Tempo Real , Fatores de TempoRESUMO
Extracellular matrix mineralization is important for mechanical stability of the skeleton and for calcium and phosphate storage. Professional mineral-disposing cell types are hypertrophic chondrocytes, odontoblasts, ameloblasts and osteoblasts. Since ectopic mineralization causes tissue dysfunction mineralization inhibitors and promoting factors have to be kept in close balance. The most prominent inhibitors are fetuin-A, matrix-Gla-protein (MGP), SIGBLING proteins and pyrophosphate. In spite of their ubiquitous presence, their loss entails a specific rather than a stereotypic pattern of ectopic mineralization. Typical sites of pathological mineral accumulation are connective tissues, articular cartilage, and vessels. Associated common human pathologies are degenerative joint disorders and arteriosclerosis. This article gives a summary on what we have learned from different mouse models with pathologic mineralization phenotypes about the role of these inhibitors and the regulation of mineralization promoting factors.
Assuntos
Doenças Ósseas Metabólicas/fisiopatologia , Calcificação Fisiológica/fisiologia , Modelos Animais de Doenças , Fenótipo , Animais , Doenças Ósseas Metabólicas/metabolismo , Fosfatos de Cálcio/metabolismo , Glucuronidase/deficiência , Glucuronidase/metabolismo , Proteínas Klotho , Camundongos , Camundongos Knockout , Osteocalcina/deficiência , Osteocalcina/metabolismo , Osteoprotegerina/deficiência , Osteoprotegerina/metabolismo , alfa-2-Glicoproteína-HS/deficiência , alfa-2-Glicoproteína-HS/metabolismoAssuntos
Osso e Ossos/metabolismo , Fertilidade/fisiologia , Osteocalcina/metabolismo , Testosterona/biossíntese , Envelhecimento/fisiologia , Animais , Metabolismo Energético , Estrogênios/fisiologia , Feminino , Fertilidade/genética , Humanos , Masculino , Camundongos , Osteoblastos/metabolismo , Osteocalcina/deficiência , Osteocalcina/genética , Osteogênese/fisiologia , Receptores Acoplados a Proteínas G/metabolismo , Caracteres Sexuais , Testículo/metabolismo , Testículo/fisiologia , Testosterona/sangueAssuntos
Osso e Ossos/fisiologia , Metabolismo Energético , Glucose/metabolismo , Animais , Remodelação Óssea , Diabetes Mellitus/metabolismo , Diabetes Mellitus/terapia , Feminino , Humanos , Insulina/metabolismo , Secreção de Insulina , Ilhotas Pancreáticas/metabolismo , Leptina/deficiência , Leptina/genética , Leptina/metabolismo , Camundongos , Obesidade/metabolismo , Osteocalcina/sangue , Osteocalcina/deficiência , Osteocalcina/genética , Osteocalcina/metabolismo , Osteoporose/metabolismo , Receptor de Insulina/deficiência , Receptor de Insulina/genética , Receptor de Insulina/metabolismoRESUMO
SUMMARY: The expression of liver genes was associated with insulin action in osteocalcin knockout mice. Our findings suggest that osteocalcin may play a role in the development of insulin resistance-associated fatty liver disease. INTRODUCTION: The expression of insulin target genes was decreased in the liver of mice lacking osteocalcin. We aimed to explore the association of liver enzymes with osteocalcin. METHODS: The associations were evaluated in a cross-sectional study (266 men) and following weight loss in 28 obese subjects (nine male, 19 females). RESULTS: In the cross-sectional study, circulating osteocalcin concentration was negatively associated with alanine transaminase (ALT) (p = 0.002) and aspartate transaminase (AST) levels (p = 0.008). These associations were especially significant in non-obese subjects (n = 191). In a multiple linear regression analysis, age (p = 0.008), insulin sensitivity (p = 0.001), and osteocalcin (p = 0.04) independently contributed to 22% of ALT variance in these latter subjects. In the weight loss study, the increase in circulating osteocalcin concentration (+70.6 ± 29.3 vs. +32 ± 13.5%, p = 0.021) was significantly greater in subjects with the highest decrease in ALT levels, despite similar baseline BMI, insulin resistance and degree of weight loss than remaining subjects. In fact, the change in ALT levels were linearly associated with those of osteocalcin (r = -0.55, p = 0.003). CONCLUSIONS: In summary, our findings suggest a bone-liver axis in which osteocalcin might be the active regulator.
Assuntos
Fígado Gorduroso/sangue , Osteocalcina/sangue , Redução de Peso/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Biomarcadores/sangue , Índice de Massa Corporal , Estudos Transversais , Fígado Gorduroso/enzimologia , Fígado Gorduroso/fisiopatologia , Feminino , Humanos , Resistência à Insulina/fisiologia , Masculino , Camundongos , Camundongos Knockout , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/dietoterapia , Osteocalcina/deficiência , Osteocalcina/fisiologia , Adulto JovemRESUMO
In healthy bone there is a balance between bone resorption and formation. When an imbalance occurs there is an overall loss of bone mass leading to an increased risk of fracture. The deterioration is typically accompanied by changes in the non-collagenous proteins in the bone. Osteocalcin (OC) is the most abundant noncollageneous bone matrix protein and it is believed to play a role in bone formation and resorption. Nanoindentation and Raman microspectroscopy have been used to correlate the mechanical and chemical properties of cortical bone from femora of OC -/- (osteocalcin deficient) mice and their wild-type controls (OC +/+). There are significant intra-bone variations in mechanics and crystallinity especially in the mid-cortical section for OC -/- mice compared to OC +/+ mice. Type-B carbonate substitution decreased significantly in the absence of osteocalcin and this appears to affect the hardness more than the elasticity. The results suggest that OC plays a role in the growth of apatite crystals in bone by increasing the degree of carbonate substitutions. The addition of these defects to the apatite's crystal lattice has little effect on elasticity, but does appear to reduce the bone's hardness.
Assuntos
Fêmur/química , Fêmur/metabolismo , Osteocalcina/deficiência , Animais , Fenômenos Biomecânicos , Técnicas de Inativação de Genes , Testes de Dureza , Masculino , Camundongos , Microquímica , Minerais/metabolismo , Nanotecnologia , Compostos Orgânicos/metabolismo , Osteocalcina/genética , Análise Espectral RamanAssuntos
Calcâneo/diagnóstico por imagem , Fraturas Ósseas/epidemiologia , Doenças Ósseas/sangue , Doenças Ósseas/diagnóstico , Osso e Ossos/química , Osso e Ossos/fisiologia , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Humanos , Fator de Crescimento Insulin-Like I , Osteocalcina/sangue , Osteocalcina/deficiência , Fatores de Risco , UltrassonografiaRESUMO
Osteocalcin, the gamma-carboxyglutamic acid-containing protein, which in most species is the predominant noncollagenous protein of bone and dentin, has been postulated to play roles in bone formation and remodeling. Recently, genetic studies showed that osteocalcin acts as an inhibitor of osteoblast function. Based on von Kossa staining and measurement of mineral apposition rates in tetracycline-labeled bones, osteocalcin knockout animals were reported to have no detectable alterations in bone mineralization. To test the hypothesis that, in addition to regulating osteoblastic activity, osteocalcin is involved in regulating mineral properties, a more sensitive assay of mineralization, Fourier transform infrared microspectroscopy (FT-IRM) was used to study thin sections of femora of 4-week-, 6-month- (intact and ovariectomized), and 9-month-old wild-type and osteocalcin-knockout mice. FT-IRM spectra provided spatially resolved measures of relative mineral and carbonate contents, and parameters indicative of apatite crystal size and perfection. No differences were detected in the mineral properties of the 4-week-old knockout and wild-type mice indicating that the mineralization process was not altered at this time point. Six-month-old wild-type animals had higher mineral contents (mineral:matrix ratios) in cortical as compared with trabecular bones; mineral contents in knockout and wild-type bones were not different. At each age studied, carbonate:phosphate ratios tended to be greater in the wild-type as compared with knockout animals. Detailed analysis of the phosphate nu1,nu3 vibrations in the spectra from 6-month-old wild-type animals indicated that the crystals were larger/more perfect in the cortical as opposed to the trabecular bones. In contrast, in the knockout animals' bones at 6 months, there were no differences between trabecular and cortical bone in terms of carbonate content or crystallite size and perfection. Spectral parameters of the cortical and trabecular bone of the knockout animals resembled those in the wild-type trabecular bone and differed from wild-type cortical bone. In ovariectomized 6-month-old animals, the mineral content (mineral:matrix ratio) in the wild-type cortices increased from periosteum to endosteum, whereas, in the knockout animals' bones, the mineral:matrix ratio was constant. Ovariectomized knockout cortices had lower carbonate:phosphate ratios than wild-type, and crystallite size and perfection resembled that in wild-type trabeculae, and did not increase from periosteum to endosteum. These spatially resolved data provide evidence that osteocalcin is required to stimulate bone mineral maturation.
Assuntos
Densidade Óssea/fisiologia , Fêmur/metabolismo , Osteocalcina/deficiência , Fatores Etários , Animais , Apatitas/análise , Carbonatos/análise , Camundongos , Camundongos Knockout , Osteocalcina/fisiologia , Ovariectomia , Fosfatos/análise , Espectroscopia de Infravermelho com Transformada de FourierRESUMO
Osteocalcin and matrix Gla protein (MGP) are two vitamin K-dependent proteins present in bone and cartilage. Transgenic mice models were recently developed to isolate the function of each of these proteins. While osteocalcin-deficient mice have increased bone formation, MGP-deficient mice have abnormal calcification leading to osteopenia, fractures, and premature death owing to arterial calcification.
Assuntos
Osso e Ossos/fisiologia , Proteínas de Ligação ao Cálcio/fisiologia , Proteínas da Matriz Extracelular , Osteocalcina/fisiologia , Vitamina K/fisiologia , Animais , Proteínas de Ligação ao Cálcio/deficiência , Humanos , Camundongos , Camundongos Transgênicos , Osteocalcina/deficiência , Proteína de Matriz GlaAssuntos
Camundongos/fisiologia , Osteocalcina/deficiência , Osteogênese/fisiologia , Animais , Densidade Óssea , Osso e Ossos/anatomia & histologia , Osso e Ossos/metabolismo , Camundongos/anatomia & histologia , Camundongos/metabolismo , Camundongos Mutantes/anatomia & histologia , Camundongos Mutantes/metabolismoRESUMO
Vertebrates constantly remodel bone. The resorption of preexisting bone by osteoclasts and the formation of new bone by osteoblasts is strictly coordinated to maintain bone mass within defined limits. A few molecular determinants of bone remodelling that affect osteoclast activity have been characterized, but the molecular determinants of osteoblast activity are unknown. To investigate the role of osteocalcin, the most abundant osteoblast-specific non-collagenous protein, we have generated osteocalcin-deficient mice. These mice develop a phenotype marked by higher bone mass and bones of improved functional quality. Histomorphometric studies done before and after ovariectomy showed that the absence of osteocalcin leads to an increase in bone formation without impairing bone resorption. To our knowledge, this study provides the first evidence that osteocalcin is a determinant of bone formation.